fundamentally it looks appealing to me at 7.25x PE and 7% yield but so it did at 95csurprised about the selling, average for today is still above 90c
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%